Our alliance with the National Cancer Institute’s Community Clinical Oncology Program (CCOP)—a network of community physicians, research centers and hospitals across the United States —permits large-scale clinical trials in an effort to evaluate the effectiveness of new ways to prevent, detect, and treat cancer. Through the CCOP, Geisinger patients have access to Phase II and III trials. Geisinger’s “Find A Study” provides a searchable list of clinical trials currently open for enrollment within the Geisinger Health System. Clinical Trials can also be found at ClinicalTrials.gov.
Phase II trials, the research study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase III trials, the research study drug or treatment is given to large groups of people (1,000-3,000) show how well it works, monitor side effects, compare it to commonly used treatments, and collect information that will allow the research drug or treatment to be used safely.
For more information, search Geisinger Clinical Trials database